Suchergebnisse - "Markowski, Mark C"

PubPharm (12)

1

Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer : the COMBAT phase II trial

enthalten in: Nature communications | 2024

von Markowski, M. | Taplin, M. | Aggarwal, R. | +17

2

Updated analyses for RESTORE cohort C : A trial of bipolar androgen therapy for patients with newly castration-resistant prostate cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Sena, L. | Wang, T. | Wang, H. | +3

CommentOn: Eur J Cancer. 2021 Feb;144:302-309. - PMID 33383350

3

A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor-targeting Agent

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Markowski, M. | Tutrone, R. | Pieczonka, C. | +7

4

Molecular and Clinical Characterization of Patients With Metastatic Castration Resistant Prostate Cancer Achieving Deep Responses to Bipolar Androgen Therapy

enthalten in: Clinical genitourinary cancer | 2022

von Markowski, M. | Kachhap, S. | De Marzo, A. | +4

5

The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2022

von Dong, L. | Su, Y. | Zhu, Y. | +10

6

A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE) : A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts

enthalten in: European urology | 2021

von Markowski, M. | Wang, H. | Sullivan, R. | +13

7

TRANSFORMER : A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Denmeade, S. | Wang, H. | Agarwal, N. | +25

8

Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on 18F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate Cancer

enthalten in: The Journal of urology | 2020

von Markowski, M. | Sedhom, R. | Fu, W. | +6

CommentIn: J Urol. 2020 Sep;204(3):502. - PMID 32589491

9

PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

enthalten in: Clinical genitourinary cancer | 2019

von Markowski, M. | Chen, Y. | Feng, Z. | +10

10

Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects

enthalten in: European urology | 2019

von Isaacsson Velho, P. | Qazi, F. | Hassan, S. | +9